Promising Potential of Actinium Pharmaceuticals’ ATNM-400 Drives Buy Rating
at www.tipranks.com (Tue, 16-Dec 8:45 AM)
Actinium Pharmaceuticals: Promising Developments and Strong Financial Position Drive Buy Rating
at www.tipranks.com (Sat, 13-Dec 12:55 PM)
Promising Preclinical Data for ATNM-400 Reinforces Buy Rating for Actinium Pharmaceuticals
at www.tipranks.com (Fri, 12-Dec 9:45 AM)
ATNM-400 Shows Superior Tumor Control and Durable Efficacy in Resistant Prostate Cancer Models
Market Chameleon (Fri, 24-Oct 11:44 AM)
